A randomized active-controlled study comparing the efficacy and safety of vernakalant to amiodarone in recent-onset atrial fibrillation

A John Camm; Alessandro Capucci; Stefan H Hohnloser; Christian Torp-Pedersen; Isabelle C Van Gelder; Brian Mangal; Gregory Beatch; AVRO Investigators

doi:10.1016/j.jacc.2010.07.046

A randomized active-controlled study comparing the efficacy and safety of vernakalant to amiodarone in recent-onset atrial fibrillation

A John Camm, Alessandro Capucci, Stefan H Hohnloser, Christian Torp-Pedersen, Isabelle C Van Gelder, Brian Mangal, Gregory Beatch, AVRO Investigators

260 Citationer (Scopus)

Abstract

This randomized double-blind study compared the efficacy and safety of intravenous vernakalant and amiodarone for the acute conversion of recent-onset atrial fibrillation (AF).

Originalsprog	Engelsk
Tidsskrift	Journal of the American College of Cardiology
Vol/bind	57
Udgave nummer	3
Sider (fra-til)	313-21
Antal sider	9
DOI	https://doi.org/10.1016/j.jacc.2010.07.046
Status	Udgivet - 18 jan. 2011

Adgang til dokumentet

10.1016/j.jacc.2010.07.046

Citationsformater

Camm, A. J., Capucci, A., Hohnloser, S. H., Torp-Pedersen, C., Van Gelder, I. C., Mangal, B., Beatch, G., & AVRO Investigators (2011). A randomized active-controlled study comparing the efficacy and safety of vernakalant to amiodarone in recent-onset atrial fibrillation. Journal of the American College of Cardiology, 57(3), 313-21. https://doi.org/10.1016/j.jacc.2010.07.046

A randomized active-controlled study comparing the efficacy and safety of vernakalant to amiodarone in recent-onset atrial fibrillation. / Camm, A John; Capucci, Alessandro; Hohnloser, Stefan H et al.
I: Journal of the American College of Cardiology, Bind 57, Nr. 3, 18.01.2011, s. 313-21.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Camm, AJ, Capucci, A, Hohnloser, SH, Torp-Pedersen, C, Van Gelder, IC, Mangal, B, Beatch, G & AVRO Investigators 2011, 'A randomized active-controlled study comparing the efficacy and safety of vernakalant to amiodarone in recent-onset atrial fibrillation', Journal of the American College of Cardiology, bind 57, nr. 3, s. 313-21. https://doi.org/10.1016/j.jacc.2010.07.046

@article{44aa414efc6549f88f73f8bbd32f6084,

title = "A randomized active-controlled study comparing the efficacy and safety of vernakalant to amiodarone in recent-onset atrial fibrillation",

abstract = "This randomized double-blind study compared the efficacy and safety of intravenous vernakalant and amiodarone for the acute conversion of recent-onset atrial fibrillation (AF).",

author = "Camm, {A John} and Alessandro Capucci and Hohnloser, {Stefan H} and Christian Torp-Pedersen and {Van Gelder}, {Isabelle C} and Brian Mangal and Gregory Beatch and {AVRO Investigators}",

year = "2011",

month = jan,

day = "18",

doi = "10.1016/j.jacc.2010.07.046",

language = "English",

volume = "57",

pages = "313--21",

journal = "Journal of the American College of Cardiology",

issn = "1558-3597",

publisher = "Elsevier Inc.",

number = "3",

}

TY - JOUR

T1 - A randomized active-controlled study comparing the efficacy and safety of vernakalant to amiodarone in recent-onset atrial fibrillation

AU - Camm, A John

AU - Capucci, Alessandro

AU - Hohnloser, Stefan H

AU - Torp-Pedersen, Christian

AU - Van Gelder, Isabelle C

AU - Mangal, Brian

AU - Beatch, Gregory

AU - AVRO Investigators

PY - 2011/1/18

Y1 - 2011/1/18

N2 - This randomized double-blind study compared the efficacy and safety of intravenous vernakalant and amiodarone for the acute conversion of recent-onset atrial fibrillation (AF).

AB - This randomized double-blind study compared the efficacy and safety of intravenous vernakalant and amiodarone for the acute conversion of recent-onset atrial fibrillation (AF).

U2 - 10.1016/j.jacc.2010.07.046

DO - 10.1016/j.jacc.2010.07.046

M3 - Journal article

C2 - 21232669

SN - 1558-3597

VL - 57

SP - 313

EP - 321

JO - Journal of the American College of Cardiology

JF - Journal of the American College of Cardiology

IS - 3

ER -

A randomized active-controlled study comparing the efficacy and safety of vernakalant to amiodarone in recent-onset atrial fibrillation

Abstract

Adgang til dokumentet

Fingeraftryk

Citationsformater